Higher COVID-19 mortality in low-income communities in the City of Cape Town – a descriptive ecological studyResearch Article Published on 2021-06-042022-10-31 Journal: Gates Open Research [Category] COVID-19, [키워드] African Cape Care census city Community COVID-19 COVID-19 mortality ecological eight Evidence Health linear relationship Low-income morbidity and mortality Mortality pandemic Rate Result South town Variation with COVID-19 [DOI] 10.12688/gatesopenres.13288.1 PMC 바로가기 [Article Type] Research Article
Infectious Respiratory Diseases Decreased during the COVID-19 Pandemic in South KoreaArticle Published on 2021-06-032022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, SARS, [키워드] age calculate cause Chickenpox contagious COVID-19 COVID-19 mitigation measure Decreased disease Diseases Effect effect size eight Evidence incidence rate Incidence rate ratio infections Infectious disease infectious respiratory disease Intervention invasive pneumococcal disease management measure Mitigation measures morbidity and mortality mumps not significant Occurrence outbreak positive Prevent provide ranged reduce respiratory Respiratory disease respiratory diseases scarlet fever Sex significantly South Korea Transmission [DOI] 10.3390/ijerph18116008 PMC 바로가기 [Article Type] Article
Impact of the COVID-19 lockdown on the adherence of stroke patients to direct oral anticoagulants: a secondary analysis from the MAAESTRO studyOriginal Communication Published on 2021-06-032022-10-29 Journal: Journal of Neurology [Category] COVID-19, MERS, SARS, [키워드] adherence Affect Analysis Antithrombotic Atrial fibrillation calculated Care COVID-19 COVID-19 outbreak Direct Oral Anticoagulation eight Electronic monitoring Impact increase in Intervention IQR ischaemic stroke lockdown median age medication medication adherence Metrics moderate MONITOR monitoring oral anticoagulant Patient patients treated Randomized reported Result stroke supplementary material Switzerland Treatment unlikely [DOI] 10.1007/s00415-021-10631-5 PMC 바로가기 [Article Type] Original Communication
Years of life lost by COVID-19 in Portugal and comparison with other European countries in 2020Research Published on 2021-06-022022-10-28 Journal: BMC Public Health [Category] COVID-19, MERS, SARS, [키워드] accounted Analysis average calculate calculated Cancer cardiovascular disease cause causes coronavirus country COVID-19 COVID-19 pandemic death defined disease disease outbreaks eight Europe European European country greater Health services Metrics Mortality mortality rate Netherland Non-COVID-19 occur Pandemics Portugal Registered Respiratory system responsible Result Spain supplementary material the WHO Year Years of life lost [DOI] 10.1186/s12889-021-11128-6 PMC 바로가기 [Article Type] Research
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 PneumoniaObservational Study Published on 2021-06-012022-10-05 Journal: Chest [Category] 임상, [키워드] 95% CI accounted Anticoagulant anticoagulant therapy anticoagulation bleeding clinical collected consecutive patient Controlled trial COVID-19 Critically ill patient defined dose eight favor French hazard ratio hemorrhage hemorrhagic events high risk High-dose ICU ICU admission Ill Impact incidence increased risk laboratory data Patient Probability Prophylactic Prophylaxis Pulmonary embolism recorded reduced risk reduction in risk SARS-COV-2 infection standardized protocol therapeutic thrombosis thrombotic thrombotic complication Treatment with COVID-19 [DOI] 10.1016/j.chest.2021.01.017 PMC 바로가기 [Article Type] Observational Study
Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-AnalysisArticle Published on 2021-06-012022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] 95% CI adverse event clinical trial clinical trials CNKI Cochrane Library COVID-19 COVID-19 vaccine COVID-19 vaccines database effective Efficacy Efficacy and safety eight Inactivated vaccine increase in injection Local Meta-analysis mRNA vaccine phase Placebo professional promoted risk Safety Seven severe symptom significantly subject systematic review the vaccine vaccination Vaccine website were used with COVID-19 [DOI] 10.3390/vaccines9060582 PMC 바로가기 [Article Type] Article
Coronavirus Disease 2019 Pneumonia and Acute Pancreatitis in a Young GirlInternal Medicine Published on 2021-06-012022-10-31 Journal: Cureus [Category] COVID-19, [키워드] abdominal pain acute pancreatitis acute respiratory syndrome added bowel breath chest X-ray Computed tomography coronavirus coronavirus disease Coronavirus disease 2019 cough COVID-19 demonstrated Dexamethasone diagnosis of COVID-19 discharged edema eight elevated epigastrium Fever Follow-up girl Inflammation initial intravenous fluids Intravenous remdesivir Lungs management Mild nausea pancrea Pancreatitis Patient peripancreatic Pneumonia polymerase chain positive reduced regimen reported SARS-CoV-2 serum serum chemistry Seven supplemental oxygen Symptom Tachycardia vomiting worsened [DOI] 10.7759/cureus.15374 PMC 바로가기 [Article Type] Internal Medicine
Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis콜히친 치료는 코로나바이러스 질병 2019(COVID-19)의 결과를 개선할 수 있습니다: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-06-012022-09-11 Journal: Clinical and experimental pharmacology & physiolog [Category] SARS, 임상, [키워드] 95% CI administration Analysis article benefit clinical trial Colchicine colchicine treatment coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients database effective Efficacy eight Europe immune immune therapy IMPROVE Inflammation Inflammatory diseases Meta-analysis mortality rate Newcastle-Ottawa Scale NOS observational studies observational study offer outcome PMC randomized clinical trial randomized trial randomized trials reducing reduction retrieved review RoB 2 searched severe COVID-19 shown statistical analysis systematic review the Newcastle-Ottawa Scale Treatment was done [DOI] 10.1111/1440-1681.13488 PMC 바로가기 [Article Type] Meta-Analysis
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study암 환자를 위한 COVID-19 백신 BNT162b2의 1회 투여 대 2회 투여의 안전성 및 면역원성: 전향적 관찰 연구의 중간 분석Observational Study Published on 2021-06-012022-09-10 Journal: The Lancet. Oncology [Category] MERS, SARS, 임상, 진단, 치료기술, [키워드] 95% CI Administered All participant All participants analysed analyses anti-S IgG antibody available data Blood blood sample Blood samples BNT162b2 BNT162b2 vaccine boost Cancer Cancer Research UK Cohort college COVID-19 COVID-19 vaccine Data analysis death dose Efficacy Efficacy and safety eight Endpoint enrolled Evidence evidence of exclusion finding first dose first vaccination FIVE Follow-up Francis Crick funding Haematological cancer Health and Care Research Wales Health Research Authority health-care healthy control healthy controls healthy controls; hospital immunogenicity immunogenicity analysis injection Injection-site pain interim analysis intramuscularly King local reaction London nasopharyngeal NHS observational study of BNT162b2 Pain participant Patient Patients with cancer patients with haematological Pfizer–BioNTech positive profile proportion prospective observational study Protein real-time RT-PCR REC receive recruited Registered reported rRT-PCR Safety SARS-CoV-2 SARS-CoV-2 spike second dose Seroconversion seropositive significantly single vaccine solid cancer Support Swab test symptomatic symptomatic COVID-19 the patient titre toxicities Toxicity Trust vaccination Vaccine Wellcome Trust [DOI] 10.1016/S1470-2045(21)00213-8 PMC 바로가기 [Article Type] Observational Study
Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection혈액투석 환자에서 SARS-CoV-2 면역 반응의 수명 및 재감염에 대한 보호Article Published on 2021-06-012022-09-11 Journal: Kidney international [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] anti-RBD antibodies antibody antibody status asymptomatic infection baseline cellular immunity center circulating antibodies circulating antibody COVID-19 detectable develop eight Evidence evidence of had no Hemodialysis humoral immune response immune responses independent of Infection investigated Kidney disease less Longevity no evidence of nucleocapsid protein Patient PCR positive receiving Receptor binding domain reduced Reinfection remained retained SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 antigen SARS-COV-2 infection screened serology seronegative seropositive significantly symptomatic and asymptomatic T cell T cell responses T-cell responses [DOI] 10.1016/j.kint.2021.03.009 PMC 바로가기 [Article Type] Article